A relationship between proinflammatory cytokines and Gal–9/TIM–3 has been reported in RA patients [23, 24], so we hypothesized that immune–checkpoint molecules are possible modulators of immunopathology in RA through their interactions with cytokines. This evidence concerns the gene LGALS9 and rheumatoid arthritis.